EUR 11.94
(5.29%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 23.03 Million EUR | -70.84% |
2022 | 78.98 Million EUR | 46.79% |
2021 | 53.8 Million EUR | 88.76% |
2020 | 28.5 Million EUR | 41.45% |
2019 | 20.15 Million EUR | 27.12% |
2018 | 15.85 Million EUR | 47.96% |
2017 | 10.71 Million EUR | 28.78% |
2016 | 8.31 Million EUR | 4734.13% |
2015 | 172.1 Thousand EUR | 83.33% |
2014 | 93.88 Thousand EUR | -52.33% |
2013 | 196.92 Thousand EUR | -20.76% |
2012 | 248.51 Thousand EUR | 263.88% |
2011 | 68.29 Thousand EUR | -96.81% |
2010 | 2.13 Million EUR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 6.05 Million EUR | 8.68% |
2024 Q2 | 7.8 Million EUR | 28.76% |
2023 Q4 | 5.57 Million EUR | -70.45% |
2023 Q3 | 18.86 Million EUR | -1.58% |
2023 FY | 23.03 Million EUR | -70.84% |
2023 Q1 | 19.86 Million EUR | -11.73% |
2023 Q2 | 19.16 Million EUR | -3.49% |
2022 Q1 | 18.36 Million EUR | -6.54% |
2022 Q2 | 18.98 Million EUR | 3.37% |
2022 FY | 78.98 Million EUR | 46.79% |
2022 Q3 | 19.14 Million EUR | 0.86% |
2022 Q4 | 22.5 Million EUR | 17.54% |
2021 Q3 | 11.65 Million EUR | 2.94% |
2021 Q1 | 11.18 Million EUR | 32.04% |
2021 Q4 | 19.64 Million EUR | 68.53% |
2021 FY | 53.8 Million EUR | 88.76% |
2021 Q2 | 11.32 Million EUR | 1.28% |
2020 Q3 | 6.84 Million EUR | -8.61% |
2020 Q2 | 7.48 Million EUR | 30.98% |
2020 Q1 | 5.71 Million EUR | -9.02% |
2020 Q4 | 8.46 Million EUR | 23.8% |
2020 FY | 28.5 Million EUR | 41.45% |
2019 Q3 | 4.63 Million EUR | 3.14% |
2019 Q1 | 4.5 Million EUR | 2.88% |
2019 FY | 20.15 Million EUR | 27.12% |
2019 Q4 | 6.28 Million EUR | 35.47% |
2019 Q2 | 4.49 Million EUR | -0.2% |
2018 Q3 | 4.37 Million EUR | 25.56% |
2018 FY | 15.85 Million EUR | 47.96% |
2018 Q2 | 3.48 Million EUR | 0.0% |
2018 Q1 | 3.48 Million EUR | 2.94% |
2018 Q4 | 4.37 Million EUR | 0.0% |
2017 FY | 10.71 Million EUR | 28.78% |
2017 Q1 | 1.94 Million EUR | -47.86% |
2017 Q2 | 1.94 Million EUR | -0.0% |
2017 Q3 | 3.38 Million EUR | 74.51% |
2017 Q4 | 3.38 Million EUR | 0.0% |
2016 Q4 | 3.72 Million EUR | 0.0% |
2016 Q1 | 355.02 Thousand EUR | 0.0% |
2016 Q2 | 355.03 Thousand EUR | 0.0% |
2016 Q3 | 3.72 Million EUR | 948.5% |
2016 FY | 8.31 Million EUR | 4734.13% |
2015 FY | 172.1 Thousand EUR | 83.33% |
2014 FY | 93.88 Thousand EUR | -52.33% |
2013 FY | 196.92 Thousand EUR | -20.76% |
2012 FY | 248.51 Thousand EUR | 263.88% |
2011 FY | 68.29 Thousand EUR | -96.81% |
2010 FY | 2.13 Million EUR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Cegedim SA | 235.64 Million EUR | 90.225% |
Guerbet SA | 550.79 Million EUR | 95.818% |
Nexus AG | 44.98 Million EUR | 48.794% |
Bastide Le Confort Médical SA | 1.91 Million EUR | -1103.501% |
Revenio Group Oyj | 18.8 Million EUR | -22.527% |
Drägerwerk AG & Co. KGaA | 1.28 Billion EUR | 98.212% |
Sartorius Aktiengesellschaft | 1.02 Billion EUR | 97.747% |
LNA Santé SA | 178.1 Million EUR | 87.067% |
Siemens Healthineers AG | 5.59 Billion EUR | 99.589% |
Equasens Société anonyme | 14.67 Million EUR | -57.021% |
Stratec SE | 41.95 Million EUR | 45.099% |